OpenClinical is an open source clinical decision support (CDS) platform that provides pathways and computer interpretable guidelines to help clinicians make better healthcare decisions. It aims to be intelligible, personalizable, justifiable, and give clinicians control. The platform can integrate with electronic medical records and be used for automated tasks and research databases. It focuses on usability, risk communication, visualizing patient journeys, and mobile access. Potential risks include maintaining high quality evidence over time, siloed care processes, reduced opportunities for discovery, and communication errors that can impact cognitive framing.
Learn how a lab in Malaysia has utilized the Roche Digital Pathology portfolio to - improve collaboration among pathologists, provide rapid turnaround time for diagnosis and consults and enrich education and training across multiple group and individual settings. Dr. Pathmanathan at Subang Jaya Medical Center encourages those reluctant to embrace digital pathology to try it for all the benefits it offers and get ahead of the curve.
Birmingham Heartlands Hospital in the U.K. has been using the Roche Digital Pathology portfolio to transform tissue diagnostics. They have streamlined collaboration, especially for their multi-disciplinary meetings and they have used digital technology in the education of new pathologists. Lab workflow has become more efficient and pathologists are now more seamlessly connected.
RTDPC-DP-0034b 6021A-3
VECTER® —
Visually Enhanced Informed Consent Documents (ICDs) written at 8th grade reading levels or below
A proven alternative to text-only informed consent forms (ICFs)
VECTER informed consent documents are written at or below the 8th grade reading level for improved subject comprehension and to ensure rights and safety of subjects.
VECTER provides significantly lower reading levels than text-only ICFs. Meets and exceeds regulatory guidelines and IRB standards to improve readability and protect participants’ rights and safety.
VECTER —
Improves comprehension, better at educating subjects
Written in plain language at 8th grade reading levels or below
Visually enhanced, easier to read
Improved comprehension
VECTER —
Accelerates informed consent development and review for sponsors and IRBs
Fit seamlessly into the normal workflow
Reviewers can edit and use track changes
Conform to your guidelines
IRB and EC members agree:
“VECTER met all of the requirements for informed consent.”
“VECTERs area sea change in informed consent.”
Our professional writers are available to:
Update your ICF templates at a 6th to 8th grade reading level
Write your next ICF — according to your guidelines — but at a lower reading level
Eliminate ambiguity, simplify sentence structure, rewrite technical language, and lower the vocabulary of your ICFs
Help you visually enhance and improve the layout of your ICFs
Webinar: Increase research efficiency and enable collaboration with the IDBS ...IDBS
Streamline patient stratification together with omics and sample management
Find out how the solution enables research scientists and clinicians across Healthcare, Pharma and other Life Sciences organizations to create a comprehensive research platform that empowers high quality decision-making. It provides the building blocks to allow clinical researchers to capture and curate their data, to manage ontologies, and to integrate, search and visualize data from clinical, biobanks and omics data sources.
In this webinar you will see how to:
- improve sample management
- capture Data Provenance
- stratify patient populations
- explore omics data in the context of clinical phenotype
- facilitate a results sharing culture between departments and collaborators
To view the webinar: http://www.idbs.com/en/news-events/list-of-webinars/2014/03/increase-research-efficiency-and-enable-collaboration-with-the-idbs-translational-science-solution/
Learn how a lab in Malaysia has utilized the Roche Digital Pathology portfolio to - improve collaboration among pathologists, provide rapid turnaround time for diagnosis and consults and enrich education and training across multiple group and individual settings. Dr. Pathmanathan at Subang Jaya Medical Center encourages those reluctant to embrace digital pathology to try it for all the benefits it offers and get ahead of the curve.
Birmingham Heartlands Hospital in the U.K. has been using the Roche Digital Pathology portfolio to transform tissue diagnostics. They have streamlined collaboration, especially for their multi-disciplinary meetings and they have used digital technology in the education of new pathologists. Lab workflow has become more efficient and pathologists are now more seamlessly connected.
RTDPC-DP-0034b 6021A-3
VECTER® —
Visually Enhanced Informed Consent Documents (ICDs) written at 8th grade reading levels or below
A proven alternative to text-only informed consent forms (ICFs)
VECTER informed consent documents are written at or below the 8th grade reading level for improved subject comprehension and to ensure rights and safety of subjects.
VECTER provides significantly lower reading levels than text-only ICFs. Meets and exceeds regulatory guidelines and IRB standards to improve readability and protect participants’ rights and safety.
VECTER —
Improves comprehension, better at educating subjects
Written in plain language at 8th grade reading levels or below
Visually enhanced, easier to read
Improved comprehension
VECTER —
Accelerates informed consent development and review for sponsors and IRBs
Fit seamlessly into the normal workflow
Reviewers can edit and use track changes
Conform to your guidelines
IRB and EC members agree:
“VECTER met all of the requirements for informed consent.”
“VECTERs area sea change in informed consent.”
Our professional writers are available to:
Update your ICF templates at a 6th to 8th grade reading level
Write your next ICF — according to your guidelines — but at a lower reading level
Eliminate ambiguity, simplify sentence structure, rewrite technical language, and lower the vocabulary of your ICFs
Help you visually enhance and improve the layout of your ICFs
Webinar: Increase research efficiency and enable collaboration with the IDBS ...IDBS
Streamline patient stratification together with omics and sample management
Find out how the solution enables research scientists and clinicians across Healthcare, Pharma and other Life Sciences organizations to create a comprehensive research platform that empowers high quality decision-making. It provides the building blocks to allow clinical researchers to capture and curate their data, to manage ontologies, and to integrate, search and visualize data from clinical, biobanks and omics data sources.
In this webinar you will see how to:
- improve sample management
- capture Data Provenance
- stratify patient populations
- explore omics data in the context of clinical phenotype
- facilitate a results sharing culture between departments and collaborators
To view the webinar: http://www.idbs.com/en/news-events/list-of-webinars/2014/03/increase-research-efficiency-and-enable-collaboration-with-the-idbs-translational-science-solution/
Guida semplice e gratuita a Twitter in cinque puntate uscita con Il Secolo XIX a cura di Luca Conti. Per approfondire trovi in libreria Twitter al 100% o Comunicare con Twitter, ed. Hoepli
Le politiche pubbliche per lo sviluppo dell’occupazione: investimenti, compe...ANPAL Servizi
A cura di Antonella Marsala (Project Manager EQUIPE2020, Italia Lavoro). Seminario di Italia Lavoro (Progetto Equipe 2020): "Innovare il settore delle calzature: scelte di impresa, relazioni industriali, politiche attive del lavoro."
Search Engine Optimization (SEO) -- University of Virginia PresentationMarketing Mojo
From search engine optimization basics to more advanced open graph tagging, this presentation provides a well-rounded education of search engine and paid search optimization. Find out how to update your website to drive visits and retarget your target market through online ads. It's all in here.
L’innovazione tecnologica di La Manuelita ANPAL Servizi
A cura di Giordano Torresi (imprenditore). Seminario di Italia Lavoro (Progetto Equipe 2020): "Innovare il settore delle calzature: scelte di impresa, relazioni industriali, politiche attive del lavoro."
A case of brand positioning and re-positioning by Lever Pakistan, when their fabric washing product RIN was instead used as a dish washer by people of Pakistan.
Closing the Loop in Healthcare Analytics - Correlating Clinical and Administrative Systems with Research Efforts to Deliver Clinical Efficiency in Real Time
Tomasz Sablinski from Transparency Life Sciences showed at the DayOne Expert event - Next Generation Clinical Trials ways to virtualize clinical trials or parts of them.
Data Harmonization for a Molecularly Driven Health SystemWarren Kibbe
Maximizing the value of data, computing, data science in an academic medical center, or 'towards a molecularly informed Learning Health System. Given in October at the University of Florida in Gainesville
Guida semplice e gratuita a Twitter in cinque puntate uscita con Il Secolo XIX a cura di Luca Conti. Per approfondire trovi in libreria Twitter al 100% o Comunicare con Twitter, ed. Hoepli
Le politiche pubbliche per lo sviluppo dell’occupazione: investimenti, compe...ANPAL Servizi
A cura di Antonella Marsala (Project Manager EQUIPE2020, Italia Lavoro). Seminario di Italia Lavoro (Progetto Equipe 2020): "Innovare il settore delle calzature: scelte di impresa, relazioni industriali, politiche attive del lavoro."
Search Engine Optimization (SEO) -- University of Virginia PresentationMarketing Mojo
From search engine optimization basics to more advanced open graph tagging, this presentation provides a well-rounded education of search engine and paid search optimization. Find out how to update your website to drive visits and retarget your target market through online ads. It's all in here.
L’innovazione tecnologica di La Manuelita ANPAL Servizi
A cura di Giordano Torresi (imprenditore). Seminario di Italia Lavoro (Progetto Equipe 2020): "Innovare il settore delle calzature: scelte di impresa, relazioni industriali, politiche attive del lavoro."
A case of brand positioning and re-positioning by Lever Pakistan, when their fabric washing product RIN was instead used as a dish washer by people of Pakistan.
Closing the Loop in Healthcare Analytics - Correlating Clinical and Administrative Systems with Research Efforts to Deliver Clinical Efficiency in Real Time
Tomasz Sablinski from Transparency Life Sciences showed at the DayOne Expert event - Next Generation Clinical Trials ways to virtualize clinical trials or parts of them.
Data Harmonization for a Molecularly Driven Health SystemWarren Kibbe
Maximizing the value of data, computing, data science in an academic medical center, or 'towards a molecularly informed Learning Health System. Given in October at the University of Florida in Gainesville
eConsent (electronic informed consent) adoption is on the rise!
100% of the Top 10 and 88% of the Top 25 Pharma have implemented eConsent - What's driving their adoption?
Learn more in our new infographic "14 Drivers of eConsent Adoption in Clinical Trials"
discussing all aspects of evidence based medicine, Introduction
History of EBM
Need of EBM
Steps to practice
Discussion - advantages/disadvantages/critical analysis
Combining Patient Records, Genomic Data and Environmental Data to Enable Tran...Perficient, Inc.
The average academic research organization (ARO) and hospital has many systems that house patient-related information, such as patient records and genomic data. Combining data from a variety of sources in an ongoing manner can enable complex and meaningful querying, reporting and analysis for the purposes of improving patient safety and care, boosting operational efficiency, and supporting personalized medicine initiatives.
In this webinar, Perficient’s Mike Grossman, a director of clinical data warehousing and analytics, and Martin Sizemore, a healthcare strategist, discussed:
-How AROs and hospitals can benefit from a systematic approach to combining data from diverse systems and utilizing a suite of data extraction, reporting, and analytical tools, in order to support a wide variety of needs and requests
-Examples of proposed solutions to real-life challenges AROs and hospitals often encounter
Supporting a Collaborative R&D Organization with a Dynamic Big Data SolutionSaama
Nikhil Gopinath presents regarding big data solutions at the Big Data and Analytics for Healthcare and Life Sciences Summit on October 18, 2017 in San Francisco, CA.
Data Harmonization for a Molecularly Driven Health SystemWarren Kibbe
Seminar for Dr. Min Zhang's Purdue Bioinformatics Seminar Series. Touched on learning health systems, the Gen3 Data Commons, the NCI Genomic Data Commons, Data Harmonization, FAIR, and open science.
Challenges in Clinical Research: Aridhia Disrupts Technology Approach to Rese...VMware Tanzu
Join Jeff Kelly, Pivotal’s Big Data Strategist and Chris Roche, Aridhia’s CEO, to learn how Big Data and data science are being applied to clinical research. Learn…
• Why research-oriented healthcare delivery organizations and academic medical centers need an ACRIS
• How improving collaboration and productivity accelerates the discovery of insights and increases competitiveness
• Why robust data security is critical to modernizing engagement between academia, industry and healthcare
• How to reduce research costs while improving commercialization opportunities
• Why enabling transparent analysis and reproducibility of research are key to scientific progress
• Best practices to get started on your digital transformation and Big Data journey
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
23. OpenClinical
A Complete CDSS platform
Based on robust decision-making theory
Open source for research into CDSS
Platform for sharing and collaboration
! Usability
! Implementation into clinical systems
29. Risks of CDSS
• Evidence quality & maintenance
• Silos of process
• Loss of discovery space
• Communication and linguistic errors
• Cognitive framing errors
• Loss of learning & desirable difficulty
In this talk an introduction to a CDSS open tool called openclinical along with my reflections as a working clinician into how to make CDSS tools succeed in the clinical environment
Introduction: Personal
First I should state my particular perspective & my journey in e-health. I have no conflict of interest in sharing this talk with you.
Emergency Medicine environment is rich in workload, decision intensity, IT use, communication and interruption, and clinical scenarios are often life threatening and time-critical.
A subject-matter expert in Emergency Medicine, decision-making, communication and workflow.
The decision support agenda is interesting because it presupposes that decisions require support and that e-tools will help patients.
But in the rest of medicine we demand evidence for common sense interventions
Pathways
CDHB, ACC, NICE are just a few example organisations with published clinical pathways. Pathways have evolved as the movement of evidence-based medicine has grown. They are more than just clinical guidelines rewritten. Although this function as a reminder of best practice is central, they crucially also act as agreements between services, reducing variability in care, obviating the need for renegotiation, and justifying resource use. This is no doubt a good thing for busy clinicians in complex work environments.
----- Meeting Notes (13/10/15 18:03) -----
5 mins max.
OpenClinical – Website Screenshot
OpenClinical is an effort to bridge the evidence gap
Evidence based assessment of DSS as an intervention along with an opportunity to create a commons for CDSS tools
Tallis - Screenshot
Is a Java based application that enables the user to create a decision support pathway using both graphical tools to schedule the skeleton of the decision process, and logical expressions to code the decision arguments and conditions within each decision step.
The logic is based on a language called pro-forma, which was developed by the Oxford team to emulate the process of human decision-making. As such it has a robust and versatile logical foundation
Pathways translated to CDSS applications
With Tallis tools can then be published to the website
If medical evidence is the written direction of care, then pathways are the evolution of medical evidence into map form, and encoding pathways into CDSS tools is the further evolution into the GPS application. The primary point of the CDSS application is to actively guide the user and therefore reduce the chances of taking a wrong turn. Here follows some example applications I created in Openclinical.
Openclinical as research base for CDSS
The site also aims to be a library of resources and a research centre for trials of CDSS applications. Importantly the licence is a research licence for use to trial at this meta-level of proving the decision support technology, not prove actual clinical care. This is an interesting concept, as trials of CDSS are not great in number and clinical outcomes not dramatic. An interesting question arises, akin to a parachute trial – if we truly believe in our clinical research and stated aims to implement this, then do we need to trial it? The answer is complex! However despite no trials of parachute use when jumping from planes, we firmly believe in their efficacy and promote their use.
----- Meeting Notes (13/10/15 18:03) -----
10 mins
OC pros and cons
The inextricable link between the content of what we’re deciding…
And the process of making a decision and the commitment to follow that pathway…
So the best we might achieve with this system is to trial complex decision flows outside of the clinical environment
Or perhaps use as educational aide memoires
Consider the analogy
A portable computer vs. A iPhone
A mapping application vs. A GPS watch
The gap
So if we’re really going to leverage CDSS we need to step up a notch…
Assuming decision quality needs to be optimised is fine… But creating technically accurate but poorly useable applications will not show a benefit
The usefulness problem – is it helpful
The usability problem – is it easy
The validity problem – is it relevant
The reason spectacular M&M gains have not been seen so far
The control group do pretty well
The incremental gains in efficiency do not often translate to life or death results in the short term (but rather population gains in the long term)
We mistakenly think of the content of decisions being all important where the process of decision making is key
The gap between clinicians and solution architects
You think we know the best way to treat people vs. medicine based on transitory best practice in a complex environment
You think the content of our decisions is separate from the way in which we make them
You think all we have is a technical challenge
So the intent to tidy up decision making and standardise as a technical challenge is not the whole solution
(image: sbts.edu)
Implementing CDSS – Clinicians and patients
As CDSS trickle into our work environment it is worth being cognizant of clinician and patient factors that are crucial to a projects success.
Firstly healthcare = a combination of competence and care. Or put another way both technically rational decision making and an emotionally relevant exchange.
Secondarily that HCI is more central that most would believe (as if somehow the UX is superfluous because the technical content is so important)
The third man problem
CDSS tools can be like an annoying third person in the room, somewhat unwanted. Stifling a good conversation like an iphone on the table
Patient Pushback
“I went to the doctor and all he did was look at his screen, and recommended me a statin. He didn’t even check my cholesterol or talk to me about it!”
Patients as individuals…
Clinician Pushback
“I hate this tool, it’s too prescriptive and medicine is not like that!”
Doctors as artists…
Linguistic Dangers – The communication space
Non-expert operation of algorithmic medicine may increase demand
(Image - http://observatorioesclerosismultiple.com)
Human Factors approach – watch what people actually do in an effort to do their job well
These tools have to feel helpful, and then rather than demand extra work from us, reduce our work
Consider 1 click and 90,000 patients on a 2 second delay = 50 hours of spinning wheels per annum
No-one designing a new messaging iPhone app would think functionality will sell in isolation of usability, speed and aesthetics.
A Human Factors Approach to what really happens in a hospital
Take photos on camera phones because hospital tech too clunky
Send texts from private phones because hospital paging and messaging systems have been too slow in development
Check drug doses on privately bought apps because the UX of formal guidelines difficult
Open private browsing windows because 2 windows is better than one
Login on other peoples cards because the privacy policy too strict (worse than poor accountability is wrong accountability)
Leveraging CDSS – Our intended project
To make this work it is more than decisions that matter
To maximize value from a CDSS project it is best to leverage what we’re doing by running the workflow. The cardiac chest pain pathway is a successful clinical pathway that is being rolled out across the South Island NZ. We are aiming to leverage the pathway so that invisibly it is doing much more than help decisions.
Enhance quality decision making
Create a clinical record
Add to a database of patient journeys for audit, research and data visualisation
Automate actions and tasks
We have to make these tools feel useful primarily, then hide the functionality that really works!
----- Meeting Notes (13/10/15 18:03) -----
15 mins
Leveraging CDSS – Our intended project
To make this work it is more than decisions that matter
UX is crucial. Lessons from web design and mobile technology
How do people understand risk?
Statistics, Charts, Stick figures…. NOT the same impression
People focus more on humanoid individuals
People have more aversion to risk than attraction to reward
So an easy calculus between benefit and harm is not necessarily easy to do
UX and visualisation key to adoption of technology
Risks of CDSS
Evidence quality & maintenance (parachute analogy)
Silos of processes
Loss of discovery space
Communication and linguistic errors
Cognitive framing errors
Loss of learning & desirable difficulty
The Dangerously Easy, The Desirably Difficult and the Dastardly
CDSS that is too easy can compel us to do things that don’t add value, and are probably dangerous. For example a mere mention of chest pain can compel an ambulance to be dispatched, an ED to organize tests, and possibly intervention to occur, with the risk that this involves.
In the sweet spot lies the desirably difficult. Requiring human work within the communication space, forcing thought and conscious action and then improving decision making in difficult domains, and allowing people to learn while they connect. This adds value in a non-obtrusive way and will be welcomed.
The dastardly is the arena for technically adequate but effectively useless IT as it is too hard, too parallel or too disruptive to workflow.
If we want to permanently shift to a new space in medicine that’s fine. But is it what we want?
Star Trek: “When you create a machine to do the work of a man, you take something away from the man”
Grand Challenges (from paper)
D.F. Sittig et al. / Journal of Biomedical Informatics 41 (2008) 387–392
Improve the Human Computer Interface
Summarize patient level information
Prioritise and Filter recommendations
Combine recommendations for patients with comorbidities
Use freetext information
Prioritise CDS content development and implementation
Mine databases to create new CDS
Disseminate best practice
Create an architecture for sharing executable CDS
Create internet accessible repositories
Gutenstein Golden rules of CDSS
Enhance decision quality
Part of a clinical workflow (invisible to clinical workflow)
Easy and compelling UX
Automates tasks
Database pathway journeys for research & visualisation
Create Clinical Record
Allow freetext variation
Maintain clinician decision autonomy
Maintain patient individuality of values
Permits discovery moments
Care with linguistically rich decisions (unless supported by Natural Language Processing or alternate analyses)
Grand Challenges (from paper)
D.F. Sittig et al. / Journal of Biomedical Informatics 41 (2008) 387–392
Improve the Human Computer Interface
Summarize patient level information
Prioritise and Filter recommendations
Combine recommendations for patients with comorbidities
Use freetext information
Prioritise CDS content development and implementation
Mine databases to create new CDS
Disseminate best practice
Create an architecture for sharing executable CDS
Create internet accessible repositories
Gutenstein Golden rules of CDSS
Enhance decision quality
Part of a clinical workflow (invisible to clinical workflow)
Easy and compelling UX
Automates tasks
Database pathway journeys for research & visualisation
Create Clinical Record
Allow freetext variation
Maintain clinician decision autonomy
Maintain patient individuality of values
Permits discovery moments
Care with linguistically rich decisions (unless supported by Natural Language Processing or alternate analyses)
----- Meeting Notes (13/10/15 18:03) -----
20 mins ideally
Conclusion
A tour of Openclinical
Clinican level application development
Research into CDSS application of clinical pathways
Sharing platform
BUT… Even if we move towards algorithmic medicine, both doctors and patients have non-algorithmic needs. We all take a step and a half towards perfect rationality but not the whole way.
My rules for implementation
Make CDSS a reliable and empathic friend, that not only tells us what to do, but quietly and delightfully helps us deliver it
Psychology of patients and doctors
UX considerations
Clinical workflow
Just like cartography led to maps which led to digital maps, satnav and eventually GPS to improve the reliability of our journeying…
…It is only when you can fit it unobtrusively in your pocket or on on your dashboard, it suggests which turn to take but can cope with variation to this, and even helpfully books your tickets
…then we will really take off.
----- Meeting Notes (13/10/15 18:03) -----
25 mins max